Business, energy, technology, markets and global industry news from Business News Today

BK polyomavirus

PharmaDeviceNews BK polyomavirus
Eurofins Viracor’s BKV inSIGHT T-cell immunity panel is designed to support BK virus immune monitoring in kidney transplant patients by adding cellular immune-response insights to conventional viral-load testing. Representative image.
Medical Devices & Diagnostics

Can Eurofins Viracor’s BKV inSIGHT panel solve a dangerous kidney transplant monitoring blind spot?

Eurofins Viracor launches BKV inSIGHT for BK virus T-cell monitoring, but adoption will depend on validation and treatment-guidance evidence.

Read More
A transplant specialist reviews kidney imaging and follow-up data as Memo Therapeutics advances potravitug as a potential targeted treatment for BK polyomavirus in kidney transplant recipients. Representative image.
Pharma & Biotech

Memo Therapeutics advances potravitug as the race for the first BK virus therapy intensifies

Memo Therapeutics’ Phase 2 data show sustained BK polyomavirus reductions and kidney-biopsy improvement, but a missed primary endpoint leaves its pivotal trial carrying the decisive burden.

Read More
Orthogon Therapeutics funding round puts fresh focus on BK virus risk in transplant patients
Pharma & Biotech

Orthogon Therapeutics adds $11m for BK virus drug, targeting one of transplant medicine’s toughest gaps

Orthogon Therapeutics raised $11M more for its BK virus drug program. Read why this transplant antiviral story could matter far beyond niche biotech.

Read More